---
title: "BCDA.US (BCDA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/BCDA.US/news.md"
symbol: "BCDA.US"
name: "BCDA.US"
parent: "https://longbridge.com/en/quote/BCDA.US.md"
datetime: "2026-05-20T18:54:07.174Z"
locales:
  - [en](https://longbridge.com/en/quote/BCDA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BCDA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BCDA.US/news.md)
---

# BCDA.US (BCDA.US) — Related News

### [Key facts: CardiAMP advances in US, Japan; FDA flags two Helix paths](https://longbridge.com/en/news/286637684.md)
*2026-05-16T07:14:55.000Z*
> BioCardia (BCDA) has launched a CardiAMP Phase III trial and advanced the CardiALLO Phase 1/2 study, reporting no safety

### [BioCardia Q1 2026 Earnings Call: Complete Transcript](https://longbridge.com/en/news/286616158.md)
*2026-05-15T20:54:15.000Z*
> BioCardia (NASDAQ:BCDA) reported Q1 2026 financial results, showing a net loss of $2.3 million and reduced expenses of $

### [BioCardia | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286562387.md)
*2026-05-15T12:08:30.000Z*
### [BioCardia | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286562375.md)
*2026-05-15T12:08:20.000Z*
### [BioCardia to Host Q1 2026 Financial Results and Corporate Update Conference Call on May 15, 2026 | BCDA Stock News](https://longbridge.com/en/news/285998512.md)
*2026-05-11T13:10:00.000Z*
> BioCardia, Inc. will host a conference call on May 15, 2026, at 4:30 PM EDT to discuss its Q1 2026 financial results and

### [BioCardia Secures FDA Pathways for Helix Catheter System](https://longbridge.com/en/news/285726486.md)
*2026-05-08T12:34:34.000Z*
> BioCardia has announced FDA agreement on two marketing clearance pathways for its Helix Transendocardial Delivery Cathet